Taiwan Liposome Company, Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 101.928 million compared to TWD 209.140 million a year ago. Operating loss was TWD 1,011.344 million compared to TWD 817.656 million a year ago. Net loss was TWD 981.517 million compared to TWD 807.522 million a year ago. Basic loss per share was TWD 12.42 compared to TWD 12.32 a year ago.